By Kristin Houser – Re-Blogged From Futurism
Scientists from the University of Pennsylvania just published the results of the first U.S. trial of CRISPR-edited cells in cancer patients — and they’re very encouraging.
In April 2019, UPenn confirmed that a team of its researchers had officially begun testing CRISPR-edited cells in humans.
For that trial, the scientists had removed immune cells from three patients with advanced, treatment-resistant cancers. They then used CRISPR-Cas9 to edit the cells in order to improve their ability to fight tumors before returning them to the patients’ bodies.